Core Insights - AMN Healthcare Services is set to release its quarterly earnings on February 19, 2026, with an anticipated EPS of $0.22 and projected revenue of approximately $723.87 million [1][6] Financial Performance - The expected EPS of $0.22 represents a significant decline of 70.7% compared to the same period last year, raising concerns among investors [2][6] - Projected revenue for the quarter is around $723.87 million, reflecting a slight decrease of 1.5% year over year, indicating challenges in maintaining growth [3][6] Market Metrics - AMN's stock opened at $19.52, with a 52-week range between $14.86 and $30.49, and a market capitalization of approximately $750 million [4] - The stock's price-to-sales ratio is 0.23, indicating a valuation of 23 cents for every dollar of sales, while the enterprise value to sales ratio is 0.54 [4] Financial Ratios - The company has a debt-to-equity ratio of 1.37, indicating a higher level of debt compared to equity [5] - A current ratio of 1.05 suggests a modest level of short-term financial health, with slightly more current assets than liabilities [5]

Core Viewpoint - AMN Healthcare Services is expected to report a significant decline in quarterly earnings and revenues, indicating potential challenges ahead for the company [1]. Financial Performance - The anticipated earnings per share (EPS) for AMN Healthcare is $0.22, reflecting a 70.7% decrease compared to the same quarter last year [1]. - Analysts forecast revenues of $723.87 million, which represents a 1.5% decline year over year [1]. Analyst Projections - There have been no revisions in the consensus EPS estimate over the past 30 days, indicating stability in analysts' expectations [1]. - The revenue from 'Physician and leadership solutions' is estimated at $168.50 million, showing a year-over-year decline of 2.7% [4]. - The revenue forecast for 'Nurse and allied solutions' stands at $465.36 million, indicating a year-over-year increase of 2.4% [4]. - The projected revenue for 'Technology and workforce solutions' is $89.97 million, reflecting a significant year-over-year decline of 15.9% [5]. Segment Operating Income - The estimated segment operating income for 'Nurse and allied solutions' is $32.42 million, down from $38.93 million in the previous year [5]. - Analysts predict 'Segment operating income- Technology and workforce solutions' will reach $29.93 million, a decrease from $40.28 million reported in the same quarter last year [6]. - The expected segment operating income for 'Physician and leadership solutions' is $13.80 million, down from $17.03 million year-over-year [6]. Stock Performance - Over the past month, AMN Healthcare shares have declined by 14.6%, contrasting with a 1.4% decline in the Zacks S&P 500 composite [6]. - AMN Healthcare holds a Zacks Rank of 4 (Sell), suggesting it may underperform the overall market in the near future [6].

Financial Data and Key Metrics Changes - The company reported a solid fourth quarter with $1.8 billion in revenue, of which $1.1 billion was digital revenue, reflecting a 10% year-over-year growth [15][14] - Adjusted EBITDA for the year was $331 million, with digital EBITDA margins remaining flat year-over-year at 28% [15][14] - In Q4, adjusted EBITDA grew 9% in digital, with incremental digital margins at 26% [14][15] Business Line Data and Key Metrics Changes - Digital revenue grew by 14% in Q4, driven by advertising (up 9%), performance marketing (up 17%), and licensing (up 36%) [13][14] - The print segment saw a decline of 23%, attributed to a prior period's political advertising revenue and ongoing sectoral decline [14] - Care revenue declined by 9% in Q4, with enterprise revenue down 13% due to tightened employer benefits spending [23] Market Data and Key Metrics Changes - Core web sessions decreased by 13% year-over-year, primarily due to a 50% drop in Google Search referrals over the last two years [19] - Non-session-based revenue sources now comprise about 38% of total digital revenue, growing 37% year-over-year in Q4 [21] - Off-platform views nearly doubled in the last two years, with a 43% year-over-year growth last quarter [20] Company Strategy and Development Direction - The company is focused on transforming traditional content businesses into new consumer products and services, aiming for stronger revenue streams [5][11] - There is a significant emphasis on off-platform strategies and expanding brand presence across social media and other platforms [4][20] - The company plans to continue evaluating buybacks and is optimistic about the growth potential in its People segment [12][29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate AI disruptions and highlighted the strength of its brands [4][12] - The outlook for 2026 is bullish, with expectations for People to exceed conservative guidance due to strong momentum [32] - Management noted that the advertising market remains generally favorable, with specific strengths in health, pharma, and travel sectors [94] Other Important Information - The company will stop providing quarterly guidance to focus on long-term value creation, while still offering annual guidance [26] - The company expects litigation expenses related to Google AdTech litigation to impact corporate expenses significantly [27] - Corporate adjusted EBITDA was $23 million, down from the previous year, as the company continues to reduce overhead [24] Q&A Session Summary Question: Could you elaborate on the key drivers of non-session-based revenue growth? - Management highlighted that the growth is driven by diversifying traffic sources and developing new distribution channels, moving away from reliance on Google [34][36] Question: What are IAC's M&A aspirations? - Management indicated interest in finding unique opportunities like MGM but noted a lack of attractive options currently available [50] Question: How scalable are the new curated experiences at People? - Management emphasized the importance of direct relationships with audiences and advertisers, noting strong engagement metrics from new products like MyRecipes and the People app [61][62] Question: What is the outlook for the Care segment? - Management expects Care revenue to return to growth by midyear, driven by product improvements and marketing investments [23] Question: Can you provide an update on the Google litigation? - Management stated that the litigation is based on antitrust claims against Google, with expectations to recover significant damages [86][87]

Core Insights - Vivian Health, Inc. has appointed Bill Kong as CEO to lead the company into its next growth phase, focusing on AI-driven innovation and product development [1][2] - Co-founder Parth Bhakta transitions to Executive Chairman, collaborating closely with Kong and the executive team to shape long-term strategy [2][4] - Vivian Health has achieved over 50x revenue growth since its acquisition by IAC, now supporting 2.7 million clinicians and facilitating over $1.5 billion in annual healthcare labor spend [3][4] Leadership Changes - Bill Kong succeeds Parth Bhakta as CEO, while Bhakta will focus on long-term strategy as Executive Chairman [2][7] - Adam Greenberg expands his role to President & CFO, overseeing financial strategy and operations [2] - Kong brings over 20 years of experience in management and marketing, having previously served as Chief Marketing Officer at Rover and Chief Digital Marketing Officer at Sears [5][6] Company Performance - Vivian Health has grown into the leading healthcare talent marketplace since its founding in 2017, with millions of job listings available [4][8] - The company is now profitable and positioned at the forefront of healthcare staffing transformation in the AI era [4][5] - The platform features intelligent matching and transparent salary information, catering to over 2.7 million healthcare professionals [8]

Group 1 - AMN Healthcare Services is experiencing a significant downturn in the healthcare contingent labor market, particularly in the nursing segment, following the end of the COVID pandemic [1] - The company is focused on identifying opportunities for substantial revenue and earnings growth that are not fully reflected in current market prices [1] - The investment strategy emphasizes long-term holding periods, with a preference for profitable companies [1] Group 2 - The article highlights the importance of writing as a tool for crystallizing thoughts and maintaining rigor in the research process [1] - The author expresses a commitment to accountability in investment decisions and encourages similar practices among active investors [1] - Seeking Alpha is recognized as a valuable resource for investors, fostering a community for sharing insights and analyses [1]

Core Insights - Adecco has acquired Advantis Medical Staffing, enhancing its healthcare staffing capabilities in the U.S. [1][2] - The acquisition is a strategic move to strengthen Adecco's position in the North American healthcare sector, which is a significant and durable talent market [2][4] Company Overview - Adecco is a leading global workforce solutions provider, aiming to connect skills with opportunities and optimize workforce solutions for long-term success [5] - The company currently provides jobs for over 600,000 people daily, with a goal to increase this number to 850,000 in the coming years [5] Advantis Medical Staffing - Advantis Medical is a tech-enabled healthcare staffing company based in Dallas, Texas, specializing in travel nursing and allied health staffing across all 50 states [6][7] - The organization is recognized for its innovative recruiting model, combining AI-enhanced platforms with experienced staffing professionals to ensure high-quality clinician placements [6][7] Strategic Importance - The acquisition allows Adecco to leverage Advantis Medical's high-touch service and advanced technology, aligning with the future of work and enhancing healthcare staffing solutions [4][6] - Advantis Medical's operational excellence and relationship-driven model have earned it a strong reputation in the healthcare ecosystem, which will be further amplified through the partnership with Adecco [3][7]

Core Viewpoint - AMN Healthcare Services, Inc. is set to discuss its fourth quarter and full year 2025 financial results along with the first quarter 2026 outlook in a conference call scheduled for February 19, 2026 [1] Group 1: Financial Results and Conference Call - The conference call will take place at 5:00 p.m. Eastern Time on February 19, 2026, following an earnings news release expected to be issued at approximately 4:15 p.m. Eastern Time on the same day [1] - A live webcast of the call will be accessible through a provided link and will also be available on AMN Healthcare's investor relations website [2] - After the call, a replay of the webcast will be available on the Company's investor relations website [3] Group 2: Company Overview - AMN Healthcare is recognized as a leader and innovator in total talent solutions for healthcare, focusing on improving care delivery through workforce solutions [4] - In 2025, AMN Healthcare professionals reached millions of patients across more than 2,000 healthcare systems, including 87 percent of the top systems nationwide [4] - The Company offers a comprehensive network of quality healthcare professionals and a fully integrated suite of customizable workforce technologies [4] Group 3: Investor Relations - The Company's common stock is listed under the symbol "AMN" on the New York Stock Exchange [5] - AMN Healthcare provides various channels for distributing information, including news releases, investor presentations, webcasts, and SEC filings, available on their investor relations website [5] - Interested parties can register for email alerts and RSS feeds for updates [5]

Core Viewpoint - Cross Country Healthcare has announced a leadership transition, appointing Kevin C. Clark as the new President and CEO, effective December 14, 2025, following the separation of John A. Martins from the company [1][2]. Group 1: Leadership Transition - John A. Martins has separated from Cross Country Healthcare and ceased to serve on the Board of Directors [1]. - Kevin C. Clark, the current Chairman and co-founder of the company, will succeed Martins as President and CEO while continuing his role as Chairman [1][2]. - Clark has nearly 40 years of experience in the healthcare staffing industry and has previously led Cross Country from 2019 to 2022, a period marked by rapid growth and strong financial results [2]. Group 2: Strategic Vision - The Board believes that Clark's return as CEO is timely, especially after the termination of the transaction with Aya Healthcare, and is expected to usher in a new era of innovative, tech-enabled workforce solutions [3]. - Clark emphasized the company's opportunity to redefine its trajectory as a leader in tech-enabled workforce solutions, leveraging its nearly 40-year legacy [3]. - The company plans to sharpen its focus, reduce costs, and optimize capital allocation to drive sustainable, long-term profitable growth for shareholders [3]. Group 3: Company Overview - Cross Country Healthcare is a market-leading, tech-enabled workforce solutions and advisory firm with nearly 40 years of industry experience [4]. - The company aims to help clients tackle complex labor-related challenges and achieve high-quality outcomes through data-driven insights [4].

Group 1 - The use of temporary staffing, particularly temporary nurses, remains elevated in hospitals five years post-coronavirus pandemic due to attrition and burnout in the sector [3] - Aya Healthcare and Cross Country Healthcare, two major U.S. healthcare staffing companies, announced a $615 million acquisition that was intended to close in the first half of 2025 [4] - The Federal Trade Commission (FTC) identified significant competitive concerns regarding the acquisition, leading to its abandonment after prolonged review [7] Group 2 - The merger's waiting period was extended multiple times due to compliance with antitrust law and requests for additional information from the FTC [5][6] - The 43-day government shutdown starting October 1 delayed the FTC's review process, ultimately exceeding the merger's new termination date [6] - The acquisition was expected to enhance Aya's technology services into non-clinical settings and strengthen both companies' positions in the healthcare staffing market [7]

Core Insights - AMN Healthcare Services reported a third-quarter earnings beat, but shares fell 0.9% due to significant year-over-year declines in revenue and profits [1][2] - Revenue for the quarter was $634.5 million, down 7.7% from the previous year, while adjusted earnings per share were $0.39, a decrease from $0.61 in the same quarter last year [2] - Sales volumes fell 10.6% year-over-year, indicating weakening demand, and free cash flow margin contracted to 3.6% from 6.9% a year ago [2] - The company’s guidance for the fourth quarter suggests continued challenges, forecasting a 1.7% year-over-year revenue decline [2] Market Reaction - The stock has shown extreme volatility, with 34 moves greater than 5% over the last year, indicating that the market considers the recent news significant but not fundamentally altering its perception of the business [4] - AMN Healthcare Services has declined 23.7% since the beginning of the year and is trading 54.3% below its 52-week high of $40.92 from November 2024 [6] Analyst Insights - Truist Securities recently reiterated a "Buy" rating and increased its price target for AMN Healthcare Services from $20.00 to $24.00, reflecting a positive outlook on the company's future performance [5]